1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Alzheimer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Alzheimer - Pipeline Products by Stage of Development 19
3.2 Alzheimer - Pipeline Products by Territory 20
3.3 Alzheimer - Pipeline Products by Regulatory Path 21
3.4 Alzheimer - Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer - Ongoing Clinical Trials 23
4 Alzheimer - Pipeline Products under Development by Companies 24
4.1 Alzheimer Companies - Pipeline Products by Stage of Development 24
4.2 Alzheimer - Pipeline Products by Stage of Development 29
5 Alzheimer Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.1.1 AC Immune SA Pipeline Products and Ongoing Clinical Trials Overview 34
5.2 Acobiom Company Overview 37
5.2.1 Acobiom Pipeline Products and Ongoing Clinical Trials Overview 37
5.3 Acumen Pharmaceuticals, Inc. Company Overview 40
5.3.1 Acumen Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
5.4 Adlyfe Inc. Company Overview 42
5.4.1 Adlyfe Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.5 Advanced Genomic Technology, LLC Company Overview 43
5.5.1 Advanced Genomic Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 43
5.6 ADx NeuroSciences NV Company Overview 44
5.6.1 ADx NeuroSciences NV Pipeline Products and Ongoing Clinical Trials Overview 44
5.7 Akrivis Technologies, LLC Company Overview 58
5.7.1 Akrivis Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 58
5.8 Alere Inc. Company Overview 59
5.8.1 Alere Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
5.9 Alzhyme Pty Ltd Company Overview 61
5.9.1 Alzhyme Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 61
5.10 Amarantus Bioscience Holdings, Inc. Company Overview 62
5.10.1 Amarantus Bioscience Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
5.11 Applied Proteomics, Inc. Company Overview 66
5.11.1 Applied Proteomics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
5.12 Araclon Biotech, S.L. Company Overview 67
5.12.1 Araclon Biotech, S.L. Pipeline Products and Ongoing Clinical Trials Overview 67
5.13 Banyan Biomarkers, Inc. Company Overview 68
5.13.1 Banyan Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 68
5.14 BioArctic Neuroscience AB Company Overview 69
5.14.1 BioArctic Neuroscience AB Pipeline Products and Ongoing Clinical Trials Overview 69
5.15 biOasis Technologies Inc. Company Overview 70
5.15.1 biOasis Technologies Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
5.16 Biomedical Development Corporation Company Overview 71
5.16.1 Biomedical Development Corporation Pipeline Products and Ongoing Clinical Trials Overview 71
5.17 BioSystems International Company Overview 72
5.17.1 BioSystems International Pipeline Products and Ongoing Clinical Trials Overview 72
5.18 C2N Diagnostics LLC Company Overview 73
5.18.1 C2N Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 73
5.19 Chronix Biomedical, Inc. Company Overview 74
5.19.1 Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
5.20 Cognoptix, Inc. Company Overview 76
5.20.1 Cognoptix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 76
5.21 Columbia University Company Overview 80
5.21.1 Columbia University Pipeline Products and Ongoing Clinical Trials Overview 80
5.22 CompanDX Ltd. Company Overview 83
5.22.1 CompanDX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 83
5.23 Consejo Superior de Investigaciones Cientificas Company Overview 84
5.23.1 Consejo Superior de Investigaciones Cientificas Pipeline Products and Ongoing Clinical Trials Overview 84
5.24 Cymedx Company Overview 86
5.24.1 Cymedx Pipeline Products and Ongoing Clinical Trials Overview 86
5.25 DiaGenic ASA Company Overview 87
5.25.1 DiaGenic ASA Pipeline Products and Ongoing Clinical Trials Overview 87
5.26 DiamiR LLC Company Overview 94
5.26.1 DiamiR LLC Pipeline Products and Ongoing Clinical Trials Overview 94
5.27 DiaPat GmbH Company Overview 95
5.27.1 DiaPat GmbH Pipeline Products and Ongoing Clinical Trials Overview 95
5.28 Diaxonhit S.A. Company Overview 96
5.28.1 Diaxonhit S.A. Pipeline Products and Ongoing Clinical Trials Overview 96
5.29 Dr. Grossegger and Drbal GmbH Company Overview 97
5.29.1 Dr. Grossegger and Drbal GmbH Pipeline Products and Ongoing Clinical Trials Overview 97
5.30 DS Pharma Biomedical Co., Ltd. Company Overview 98
5.30.1 DS Pharma Biomedical Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 98
5.31 Durin Technologies, Inc. Company Overview 99
5.31.1 Durin Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 99
5.32 Emory University Company Overview 100
5.32.1 Emory University Pipeline Products and Ongoing Clinical Trials Overview 100
5.33 Fianostics GmbH Company Overview 101
5.33.1 Fianostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 101
5.34 Gene Solutions LLC Company Overview 102
5.34.1 Gene Solutions LLC Pipeline Products and Ongoing Clinical Trials Overview 102
5.35 GeneNews Limited Company Overview 103
5.35.1 GeneNews Limited Pipeline Products and Ongoing Clinical Trials Overview 103
5.36 Genentech, Inc. Company Overview 105
5.36.1 Genentech, Inc. Pipeline Products and Ongoing Clinical Trials Overview 105
5.37 Georg-August-Universitat Gottingen Company Overview 107
5.37.1 Georg-August-Universitat Gottingen Pipeline Products and Ongoing Clinical Trials Overview 107
5.38 Ghent University Company Overview 110
5.38.1 Ghent University Pipeline Products and Ongoing Clinical Trials Overview 110
5.39 HealthTell, Inc. Company Overview 111
5.39.1 HealthTell, Inc. Pipeline Products and Ongoing Clinical Trials Overview 111
5.40 ICDD-sas Company Overview 112
5.40.1 ICDD-sas Pipeline Products and Ongoing Clinical Trials Overview 112
5.41 Innovative California Biosciences International, Inc. Company Overview 115
5.41.1 Innovative California Biosciences International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 115
5.42 Innovative Health Diagnostics Company Overview 122
5.42.1 Innovative Health Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 122
5.43 Institut National de la Sante et de la Recherche Medicale Company Overview 123
5.43.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products and Ongoing Clinical Trials Overview 123
5.44 Instituto de Estructura de la Materia Company Overview 124
5.44.1 Instituto de Estructura de la Materia Pipeline Products and Ongoing Clinical Trials Overview 124
5.45 Integrated Diagnostics Inc. Company Overview 125
5.45.1 Integrated Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 125
5.46 Janssen Pharmaceutica N.V. Company Overview 126
5.46.1 Janssen Pharmaceutica N.V. Pipeline Products and Ongoing Clinical Trials Overview 126
5.47 KineMed, Inc. Company Overview 127
5.47.1 KineMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 127
5.48 Laboratory Corporation of America Holdings Company Overview 128
5.48.1 Laboratory Corporation of America Holdings Pipeline Products and Ongoing Clinical Trials Overview 128
5.49 McGill University Health Center Company Overview 130
5.49.1 McGill University Health Center Pipeline Products and Ongoing Clinical Trials Overview 130
5.50 Memory Dx, LLC Company Overview 131
5.50.1 Memory Dx, LLC Pipeline Products and Ongoing Clinical Trials Overview 131
5.51 Meso Scale Diagnostics LLC Company Overview 132
5.51.1 Meso Scale Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 132
5.52 Myriad Genetics, Inc. Company Overview 133
5.52.1 Myriad Genetics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 133
5.53 NanoSomiX, Inc. Company Overview 135
5.53.1 NanoSomiX, Inc. Pipeline Products and Ongoing Clinical Trials Overview 135
5.54 Nanosphere, Inc. Company Overview 137
5.54.1 Nanosphere, Inc. Pipeline Products and Ongoing Clinical Trials Overview 137
5.55 Neuron Biopharma SA Company Overview 139
5.55.1 Neuron Biopharma SA Pipeline Products and Ongoing Clinical Trials Overview 139
5.56 NeuroQuest, Ltd. Company Overview 141
5.56.1 NeuroQuest, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 141
5.57 Neurotrope Bioscience, Inc. Company Overview 142
5.57.1 Neurotrope Bioscience, Inc. Pipeline Products and Ongoing Clinical Trials Overview 142
5.58 NeuroVision Imaging LLC. Company Overview 143
5.58.1 NeuroVision Imaging LLC. Pipeline Products and Ongoing Clinical Trials Overview 143
5.59 Newcastle University Company Overview 144
5.59.1 Newcastle University Pipeline Products and Ongoing Clinical Trials Overview 144
5.60 NextGen Sciences Dx Inc Company Overview 146
5.60.1 NextGen Sciences Dx Inc Pipeline Products and Ongoing Clinical Trials Overview 146
5.61 Novel Bio-spectrum Technologies, Inc. Company Overview 147
5.61.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 147
5.62 Oligomerix, inc. Company Overview 148
5.62.1 Oligomerix, inc. Pipeline Products and Ongoing Clinical Trials Overview 148
5.63 OPKO Health, Inc. Company Overview 149
5.63.1 OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 149
5.64 Orasi Medical, Inc. Company Overview 152
5.64.1 Orasi Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 152
5.65 Oregon Health and Science University Company Overview 156
5.65.1 Oregon Health and Science University Pipeline Products and Ongoing Clinical Trials Overview 156
5.66 Oryzon Genomics S.A. Company Overview 157
5.66.1 Oryzon Genomics S.A. Pipeline Products and Ongoing Clinical Trials Overview 157
5.67 Oxford Biodynamics Limited Company Overview 159
5.67.1 Oxford Biodynamics Limited Pipeline Products and Ongoing Clinical Trials Overview 159
5.68 PDx BioTech Company Overview 161
5.68.1 PDx BioTech Pipeline Products and Ongoing Clinical Trials Overview 161
5.69 PeriRx LLC Company Overview 162
5.69.1 PeriRx LLC Pipeline Products and Ongoing Clinical Trials Overview 162
5.70 Pre Diagnostics AS Company Overview 163
5.70.1 Pre Diagnostics AS Pipeline Products and Ongoing Clinical Trials Overview 163
5.71 Predemtec GmbH Company Overview 164
5.71.1 Predemtec GmbH Pipeline Products and Ongoing Clinical Trials Overview 164
5.72 ProMIS Neurosciences Inc. Company Overview 165
5.72.1 ProMIS Neurosciences Inc. Pipeline Products and Ongoing Clinical Trials Overview 165
5.73 Proplex Technologies, Llc Company Overview 167
5.73.1 Proplex Technologies, Llc Pipeline Products and Ongoing Clinical Trials Overview 167
5.74 Protagen AG Company Overview 169
5.74.1 Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 169
5.75 Proteome Sciences Plc Company Overview 170
5.75.1 Proteome Sciences Plc Pipeline Products and Ongoing Clinical Trials Overview 170
5.76 Proteomics International Pty Ltd Company Overview 173
5.76.1 Proteomics International Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 173
5.77 Quanterix Corporation Company Overview 174
5.77.1 Quanterix Corporation Pipeline Products and Ongoing Clinical Trials Overview 174
5.78 Redox Diagnostics LLC Company Overview 175
5.78.1 Redox Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 175
5.79 Saladax Biomedical, Inc. Company Overview 176
5.79.1 Saladax Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 176
5.80 Satoris, Inc. Company Overview 177
5.80.1 Satoris, Inc. Pipeline Products and Ongoing Clinical Trials Overview 177
5.81 Scout Diagnostics, LLC Company Overview 178
5.81.1 Scout Diagnostics, LLC Pipeline Products and Ongoing Clinical Trials Overview 178
5.82 Singulex, Inc. Company Overview 179
5.82.1 Singulex, Inc. Pipeline Products and Ongoing Clinical Trials Overview 179
5.83 SomaLogic, Inc. Company Overview 180
5.83.1 SomaLogic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 180
5.84 Takeda Pharmaceuticals International AG Company Overview 181
5.84.1 Takeda Pharmaceuticals International AG Pipeline Products and Ongoing Clinical Trials Overview 181
5.85 The Johns Hopkins University Company Overview 183
5.85.1 The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 183
5.86 The University of Melbourne Company Overview 184
5.86.1 The University of Melbourne Pipeline Products and Ongoing Clinical Trials Overview 184
5.87 Trinity College Dublin Company Overview 185
5.87.1 Trinity College Dublin Pipeline Products and Ongoing Clinical Trials Overview 185
5.88 True Diagnostics, Inc. Company Overview 186
5.88.1 True Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 186
5.89 University of California, Irvine Company Overview 187
5.89.1 University of California, Irvine Pipeline Products and Ongoing Clinical Trials Overview 187
5.90 University of Chicago Company Overview 188
5.90.1 University of Chicago Pipeline Products and Ongoing Clinical Trials Overview 188
5.91 University of Georgia Company Overview 189
5.91.1 University of Georgia Pipeline Products and Ongoing Clinical Trials Overview 189
5.92 University of Luxembourg Company Overview 190
5.92.1 University of Luxembourg Pipeline Products and Ongoing Clinical Trials Overview 190
5.93 University of Nottingham Company Overview 191
5.93.1 University of Nottingham Pipeline Products and Ongoing Clinical Trials Overview 191
5.94 University of South Florida Company Overview 192
5.94.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 192
5.95 University of Texas Health Science Center at Houston Company Overview 193
5.95.1 University of Texas Health Science Center at Houston Pipeline Products and Ongoing Clinical Trials Overview 193
5.96 University of Texas Southwestern Medical Center at Dallas Company Overview 195
5.96.1 University of Texas Southwestern Medical Center at Dallas Pipeline Products and Ongoing Clinical Trials Overview 195
5.97 US Biomarkers, Inc. Company Overview 197
5.97.1 US Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 197
5.98 Vermillion, Inc. Company Overview 198
5.98.1 Vermillion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 198
5.99 Vitruvian Biomedical, Inc. Company Overview 200
5.99.1 Vitruvian Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 200
5.100 Washington University in St. Louis Company Overview 201
5.100.1 Washington University in St. Louis Pipeline Products and Ongoing Clinical Trials Overview 201
5.101 XRGenomics LTD Company Overview 205
5.101.1 XRGenomics LTD Pipeline Products and Ongoing Clinical Trials Overview 205
5.102 Zoiray Technologies Inc. Company Overview 206
5.102.1 Zoiray Technologies Inc. Pipeline Products and Ongoing Clinical Trials Overview 206
6 Alzheimer- Recent Developments 207
7 Appendix 213
7.1 Methodology 213
7.2 About GlobalData 215
7.3 Contact Us 216
7.4 Disclaimer 216

1.1 List of Tables
Table 1: Alzheimer - Pipeline Products by Stage of Development 19
Table 2: Alzheimer - Pipeline Products by Territory 20
Table 3: Alzheimer - Pipeline Products by Regulatory Path 21
Table 4: Alzheimer - Pipeline Products by Estimated Approval Date 22
Table 5: Alzheimer - Ongoing Clinical Trials 23
Table 6: Alzheimer Companies - Pipeline Products by Stage of Development 24
Table 7: Alzheimer - Pipeline Products by Stage of Development 29
Table 8: AC Immune SA Pipeline Products and Ongoing Clinical Trials Overview 34
Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 35
Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 35
Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 36
Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 36
Table 13: Acobiom Pipeline Products and Ongoing Clinical Trials Overview 37
Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 38
Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 38
Table 16: Diagnostic Test - Alzheimer's Disease - Product Status 39
Table 17: Diagnostic Test - Alzheimer's Disease - Product Description 39
Table 18: Acumen Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 41
Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 41
Table 21: Adlyfe Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 22: Diagnostic Assay - Alzheimer's Disease - Product Status 42
Table 23: Diagnostic Assay - Alzheimer's Disease - Product Description 42
Table 24: Advanced Genomic Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 43
Table 25: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status 43
Table 26: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description 43
Table 27: ADx NeuroSciences NV Pipeline Products and Ongoing Clinical Trials Overview 44
Table 28: ADDL'S Biomarker Test - Product Status 45
Table 29: ADDL'S Biomarker Test - Product Description 45
Table 30: Alpha-Synuclein Biomarker Test - Product Status 46
Table 31: Alpha-Synuclein Biomarker Test - Product Description 46
Table 32: APO E4 Biomarker Test - Product Status 47
Table 33: APO E4 Biomarker Test - Product Description 47
Table 34: Aß 1-38 CSF Biomarker Test - Product Status 48
Table 35: Aß 1-38 CSF Biomarker Test - Product Description 48
Table 36: Aß 1-40, Aß 1-42, Aß 1-38 Plasma Biomarker Test - Product Status 49
Table 37: Aß 1-40, Aß 1-42, Aß 1-38 Plasma Biomarker Test - Product Description 49
Table 38: BACE 1 Biomarker Test - Product Status 50
Table 39: BACE 1 Biomarker Test - Product Description 50
Table 40: GLOB. P3N Aß Biomarker Test - Product Status 51
Table 41: GLOB. P3N Aß Biomarker Test - Product Description 51
Table 42: Neurofilament Biomarker Test - Product Status 52
Table 43: Neurofilament Biomarker Test - Product Description 52
Table 44: Neurogranin Biomarker Test - Product Status 53
Table 45: Neurogranin Biomarker Test - Product Description 53
Table 46: O-TAU Biomarker Test - Product Status 54
Table 47: O-TAU Biomarker Test - Product Description 54
Table 48: P-tau Biomarker Test - Product Status 55
Table 49: P-tau Biomarker Test - Product Description 55
Table 50: SNAP 25 Biomarker Test - Product Status 56
Table 51: SNAP 25 Biomarker Test - Product Description 56
Table 52: Synuclein Oligo Biomarker Test - Product Status 57
Table 53: Synuclein Oligo Biomarker Test - Product Description 57
Table 54: Akrivis Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 58
Table 55: Amyloid-ß Biomarker Test - Alzheimer's Disease - Product Status 58
Table 56: Amyloid-ß Biomarker Test - Alzheimer's Disease - Product Description 58
Table 57: Alere Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 58: AD Index - Product Status 60
Table 59: AD Index - Product Description 60
Table 60: Alzhyme Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 61
Table 61: Diagnostic Test - Alzheimer's Disease - Product Status 61
Table 62: Diagnostic Test - Alzheimer's Disease - Product Description 61
Table 63: Amarantus Bioscience Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 64: Biomarker-Based Diagnostic Assay - Alzheimer's Disease - Product Status 63
Table 65: Biomarker-Based Diagnostic Assay - Alzheimer's Disease - Product Description 63
Table 66: LymPro CLIA Test - Product Status 64
Table 67: LymPro CLIA Test - Product Description 64
Table 68: NuroPro - Alzheimer's Disease - Product Status 65
Table 69: NuroPro - Alzheimer's Disease - Product Description 65
Table 70: Applied Proteomics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 71: API Diagnostic Test - Alzheimer's Disease - Product Status 66
Table 72: API Diagnostic Test - Alzheimer's Disease - Product Description 66
Table 73: Araclon Biotech, S.L. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 74: AB cbr Diagnostic Test - Product Status 67
Table 75: AB cbr Diagnostic Test - Product Description 67
Table 76: Banyan Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 68
Table 77: Diagnostic Assay - Alzheimer's Disease - Product Status 68
Table 78: Diagnostic Assay - Alzheimer's Disease - Product Description 68
Table 79: BioArctic Neuroscience AB Pipeline Products and Ongoing Clinical Trials Overview 69
Table 80: Diagnostic Test - Alzheimer's Disease - Product Status 69
Table 81: Diagnostic Test - Alzheimer's Disease - Product Description 69
Table 82: biOasis Technologies Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 83: Cognitest - Product Status 70
Table 84: Cognitest - Product Description 70
Table 85: Biomedical Development Corporation Pipeline Products and Ongoing Clinical Trials Overview 71
Table 86: Vestibular - Topographical Memory Diagnostic Test - Product Status 71
Table 87: Vestibular - Topographical Memory Diagnostic Test - Product Description 71
Table 88: BioSystems International Pipeline Products and Ongoing Clinical Trials Overview 72
Table 89: Diagnostic Test - Alzheimer's Disease - Product Status 72
Table 90: Diagnostic Test - Alzheimer's Disease - Product Description 72
Table 91: C2N Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 73
Table 92: SILK-Aß Assay - Product Status 73
Table 93: SILK-Aß Assay - Product Description 73
Table 94: Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
Table 95: Companion Diagnostic Test - Alzheimer's Disease - Product Status 75
Table 96: Companion Diagnostic Test - Alzheimer's Disease - Product Description 75
Table 97: Cognoptix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 76
Table 98: SAPPHIRE II Eye Test - Product Status 77
Table 99: SAPPHIRE II Eye Test - Product Description 77
Table 100: Cognoptix, Inc. - Ongoing Clinical Trials Overview 78
Table 101: SAPPHIRE II Eye Test - Diagnosis of Alzheimer's Disease via Beta Amyloid Signature in the Eyes Using SAPPHIRE II : A Proof Of Concept Study 79
Table 102: Columbia University Pipeline Products and Ongoing Clinical Trials Overview 80
Table 103: bAPP Diagnostic Test - Alzheimer's Disease - Product Status 81
Table 104: bAPP Diagnostic Test - Alzheimer's Disease - Product Description 81
Table 105: Diagnostic Test - Alzheimer's Disease - Product Status 82
Table 106: Diagnostic Test - Alzheimer's Disease - Product Description 82
Table 107: CompanDX Ltd. Pipeline Products and Ongoing Clinical Trials Overview 83
Table 108: Biomarker Assay - Alzheimer's Disease - Product Status 83
Table 109: Biomarker Assay - Alzheimer's Disease - Product Description 83
Table 110: Consejo Superior de Investigaciones Cientificas Pipeline Products and Ongoing Clinical Trials Overview 84
Table 111: Diagnostic Assay - Alzheimer's Disease - Product Status 85
Table 112: Diagnostic Assay - Alzheimer's Disease - Product Description 85
Table 113: Cymedx Pipeline Products and Ongoing Clinical Trials Overview 86
Table 114: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Status 86
Table 115: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Description 86
Table 116: DiaGenic ASA Pipeline Products and Ongoing Clinical Trials Overview 87
Table 117: ADtect PLUS - Product Status 88
Table 118: ADtect PLUS - Product Description 88
Table 119: ADtect ULTRA - Product Status 89
Table 120: ADtect ULTRA - Product Description 89
Table 121: AMYtect - Product Status 90
Table 122: AMYtect - Product Description 90
Table 123: MCItect - New Version - Product Status 91
Table 124: MCItect - New Version - Product Description 91

1.2 List of Figures
Figure 1: Alzheimer - Pipeline Products by Stage of Development 19
Figure 2: Alzheimer - Pipeline Products by Territory 20
Figure 3: Alzheimer - Pipeline Products by Regulatory Path 21
Figure 4: Alzheimer - Pipeline Products by Estimated Approval Date 22
Figure 5: Alzheimer - Ongoing Clinical Trials 23

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Alzheimer’s disease ...

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Amyotrophic lateral sclerosis (ALS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global Multi Infarct Dementia Market Research Report 2016" by OBRC, is an extensive study on present state of the Multi Infarct Dementia Market. The global multi-infarct dementia is estimated to reach ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.